Department of Health and Human Services
200 Independence Avenue, S.W.
182 articles with Department of Health and Human Services
Meabco Awarded a $5.9 Million US Government Contract to Advance its BP-C2 Compound as a Medical Countermeasure for Cutaneous Radiation Injuries
Award from the National Institute of Allergy and Infectious Diseases (NIAID) Radiation and Nuclear Countermeasures Program
Mallinckrodt Will Appeal District Court Ruling in Case Involving Ongoing Acthar Medicaid Drug Rebate Dispute with the Centers for Medicare and Medicaid Services (CMS)
Company believes District Court decision misinterprets federal law and fails to address important legal requirements of the Administrative Procedure Act
Emergent BioSolutions Joins U.S. Government’s Warp Speed Program in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing
Emergent and HHS expand 2012 CIADM public-private partnership with task order valued at approximately $628 million for rapid domestic production of leading COVID-19 vaccine candidates through 2021
Apotex Corp. announced that it has donated much needed medicines in the fight against COVID-19 to U.S. Department of Health and Human Services.
Nation's Largest Kidney Patient and Professional Organizations Urge Action to Protect Patients During Reopening
The National Kidney Foundation and American Society of Nephrology join to advance the unique needs of kidney patients during COVID-19
Fifty Tablo Mobile Dialysis Systems Deployed to New York Hospitals by U.S. Department of Health and Human Services for COVID-19 Disaster Recovery Response
NYC and Long Island receive first-ever HHS emergency deployment of Outset Medical's easy-to-use technology for patients with kidney failure
AHF Welcomes U.S. Reps. Doggett and DeLauro’s Inquiry re: Gilead’s Use of Public Funds Developing COVID-19 Treatment
AIDS Healthcare Foundation praised the work of U.S. Representatives Lloyd Doggett and Rosa DeLauro for their demand for an accounting of how Gilead Sciences has used public funds to make private profit off government research for the development of remdesivir.
America's Blood Centers Partners with BARDA to Expand Collection of Convalescent Plasma for COVID-19 Patients
Community Blood Centers Nationwide Remain at the Forefront of the National Response Efforts to Increase Access to COVID-19 Convalescent Plasma [27-April-2020] WASHINGTON , April 27, 2020 /PRNewswire/ -- America's Blood Centers and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Resp
After leading a flurry of collaborations with multiple companies to hasten the development of vaccine candidates and treatments for COVID-19, Rick Bright, the director of BARDA, has abruptly departed his post for another position in the government.
In a letter to the U.S. Department of HHS, the AANA has partnered with 24 national organizations to request Secretary Alex Azar support key provisions of the U.S. president's executive order #13890, which provides a path to the permanent removal of burdensome supervision and licensure requirements for non-physician providers such as Certified Registered Nurse Anesthetists.
Cellphire, Inc. announced that the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised its third contract option valued at $33.3 million to support Cellphire's next generation platelet-based hemostatic product, Thrombosomes®, through a Phase 2 clinical trial in bleeding thrombocytopenic patients.
Vyaire is one of seven companies awarded contracts to ramp up ventilator production
General Motors Co. began mass production of the Ventec Life Systems V+Pro critical care ventilator under contract to the U.S. Department of Health and Human Services.
The American Association of Nurse Anesthetists announced today The Department of Health and Human Services began the delivery of the initial $30 billion in relief funding to healthcare providers in support of the national response to COVID-19 as part of the distribution of the $100 billion provider relief fund provided for in the Coronavirus Aid, Relief, and Economic Security Act recently passed by Congress.
OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test
OraSure Technologies, Inc. announced it has been awarded a $710,310 contract from the Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services, to develop a pan-SARS-coronavirus antigen rapid in-home self-test that uses oral fluid samples.
The U.S. Department of Health and Human Services, American Society of Nephrology and National Kidney Foundation announced that 25 innovators have been selected as winners in two categories of the first-ever KidneyX: Patient Innovator Challenge, funded by NKF.
GenMark Diagnostics, Inc., a leading provider of automated, multiplex molecular diagnostic testing systems, announced it has been awarded a grant from the Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response.
Vizient Shares Supply Strategy Recommendations to the Administration for Personal Protective Equipment and Pharmaceuticals during COVID-19 Crisis
Following its participation in the March 11 meeting at the White House with members of the Coronavirus task force, Vizient is sharing the list of recommendations it provided to the Trump administration, U.S. Department of Health and Human Services and the Centers for Medicare and Medicaid Services that focus on supply strategies for personal protective equipment and medications.
Mallinckrodt Confirms Court Decision in Lawsuit Against HHS and CMS and Provides Update Related to Global Opioid Settlement and Present Financing Activities
Mallinckrodt plc confirmed that its subsidiary, Mallinckrodt ARD LLC, received a decision from the U.S. District Court for the District of Columbia in its suit against U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services regarding the company's calculation of Medicaid drug rebates for Acthar® Gel.
Andor Health Customers are Already Prepared for Full Compliance With Key Provisions in Federal Interoperability and Health Data Exchange Rules
ThinkAndor™ mobile platform ensures full compliance with HHS interoperability regulations that align with similar Florida legislation passed in 2019, protecting providers' Medicare eligibility